Chris Calise insider trades
Open-market stock purchases and sales by Chris Calise, Director at Coeptis Therapeutics Holdings, Inc, from SEC Form 4 filings since Dec 14, 2020.
Open-market stock purchases and sales by Chris Calise, Director at Coeptis Therapeutics Holdings, Inc, from SEC Form 4 filings since Dec 14, 2020.